home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Genetic Risk For Schizophrenia And Brain Function

 
  November, 9 2006 9:09
your information resource in human molecular genetics
 
     
Variation in a gene linked with schizophrenia is associated with the occurrence of psychotic symptoms and cognitive deficits, along with reduced activity in the frontal and temporal lobes of the brain, reports a paper in the December 2006 issue of Nature Neuroscience.

The most notable symptoms of schizophrenia are delusions and hallucinations, but the full syndrome is preceded by milder psychotic behaviors and includes general cognitive deficits. Over a 10-year period, Jeremy Hall and colleagues studied young people with schizophrenic relatives, who were therefore at high risk of developing schizophrenia themselves, to assess the differences between individuals who develop symptoms and those who do not. They report that people with a variant of the neuregulin 1 - NRG1 -gene that has been previously associated with schizophrenia were more likely to develop psychotic symptoms, and to have low IQ scores, than those without the variant. Furthermore, they found that people with the risky neuregulin 1 variant showed lower activation in parts of the frontal and temporal lobes of the brain as measured with functional magnetic resonance imaging - fMRI.

The findings of this study suggest that the behavioral and neural precursors of schizophrenia may have a significant genetic contribution. Further research is required to determine the causal nature of the relationship between the reduction in brain activation and the effects of both genetic variation and cognitive dysfunction.

Author contact:

Jeremy Hall (University of Edinburgh, UK)
Please contact the author through the University of Edinburgh Press Office: Linda Menzies, E-mail Linda.Menzies@ed.ac.uk

Abstract available online.

(C) Nature Neuroscience press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.